What happens when a demonstration project ends

Grella, Christine E.; Anglin, M. Douglas; Rawson, Richard A.; Crowley, Robert T.; Hasson, Albert

doi:10.1016/s0740-5472(96)00055-4

Cited by 13 publications

(2 citation statements)

References 29 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Ethical prevention programs will face these concerns. For example, one methadone treatment program followed its clients and agency's situation for a period after funding and found that those clients not eligible for treatment under other funding left treatment (Grella, Anglin, Rawson, Crowley, and Hasson, 1996). Another project found de-funded women reported severe emotional and financial destabilization as a result of lost access to subsidized methadone maintenance treatment.…”

Section: Consider Program Integration With Other Service Providersmentioning

confidence: 99%

Prevention program sustainability: The state's perspective

Akerlund

2000

J. Community Psychol.

View full text Add to dashboard Cite

Program sustainability requires grantees to be service providers, evaluators, and fundraisers. State agencies support programs that enhance state priorities and systems, are community driven, are high quality, have ongoing evaluation, and strong management and fiscal practices. Sustainable programs are of reasonable cost and have the potential for replication, modification to meet changing community needs, and providing technology transfer and other by‐products. Planning includes identifying potential funders, developing funding goals, objectives, strategies, and timelines, marketing, providing technical assistance, and performing cost‐benefit analysis. Federal agencies should involve states in planning future federal grants and require grantees to begin sustainability planning in year one. Programs not receiving renewed funding have ethical responsibilities to participants, agency staff, and the community when services end. © 2000 John Wiley & Sons, Inc.

show abstract

Section: Consider Program Integration With Other Service Providersmentioning

confidence: 99%

Prevention program sustainability: The state's perspective

Akerlund

2000

J. Community Psychol.

View full text Add to dashboard Cite

show abstract

“…21 This context should be kept in mind when interpreting the results. The historical summary provided in two earlier articles by the authors and updated herein yield important lessons regarding the introduction of new medications into addiction health services.…”

mentioning

confidence: 99%

Longitudinal Effects of LAAM and Methadone Maintenance on Heroin Addict Behavior

Anglin¹,

Conner²,

Annon³

et al. 2008

J Behav Health Serv Res

View full text Add to dashboard Cite

Levo-alpha-acetylmethadol maintenance (LAAM) was compared to methadone maintenance (MM) on the behavioral performance of 315 heroin addicts before, during, and after 12 months of fully subsidized treatment. Assessments of drug use, criminal behavior, HIV risk behaviors, and employment and residential status were obtained at treatment intake and at 6, 12, and 18 months after admission. Treatment retention and in-treatment suppression of heroin use were significantly better for the LAAM group than for the MM group. Improvements were also noted during treatment in criminal behavior, criminal justice involvement, and employment status, and there were reductions in injection HIV risk and number of sexual partners. Most significant effects were primarily related to active participation in maintenance treatment. Under subsidized treatment, retention rates were two to four times that of similar clients in local community programs during the same period. LAAM was a useful and a potentially important addition to treatment options for opiate addiction, conferring greater retention and opiate suppression benefits. Its removal from application provides a historical lesson concerning the introduction of new medications into addiction health services.

show abstract

Substitution treatment of injecting opioid users for prevention of HIV infection

Gowing¹,

Farrell

Bornemann

et al. 2004

Cochrane Database of Systematic Reviews

View full text Add to dashboard Cite

Oral substitution treatment for opioid-dependent injecting drug users is associated with statistically significant reductions in illicit opioid use, injecting use and sharing of injecting equipment. It is also associated with reductions in the proportion of injecting drug users reporting multiple sex partners or exchanges of sex for drugs or money, but has little effect on condom use. It appears that the reductions in risk behaviours related to drug use do translate into reductions in cases of HIV infection. The lack of data from randomised controlled studies limits the strength of the evidence presented in this review. However, these findings add to the stronger evidence of effectiveness of substitution treatment on drug use, and treatment retention outcomes shown by other systematic reviews. On this basis, the provision of substitution treatment for opioid dependence in countries with emerging HIV and injecting drug use problems as well as in countries with established populations of injecting drug users should be supported.

show abstract

What happens when a demonstration project ends

Cited by 13 publications

References 29 publications

Prevention program sustainability: The state's perspective

Prevention program sustainability: The state's perspective

Longitudinal Effects of LAAM and Methadone Maintenance on Heroin Addict Behavior

Substitution treatment of injecting opioid users for prevention of HIV infection

Contact Info

Product

Resources

About